awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38152742-1321C5D6-BDF6-40CE-BB63-A64230F5207C
Q38152742-1321C5D6-BDF6-40CE-BB63-A64230F5207C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38152742-1321C5D6-BDF6-40CE-BB63-A64230F5207C
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerations.
P2860
Q38152742-1321C5D6-BDF6-40CE-BB63-A64230F5207C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38152742-1321C5D6-BDF6-40CE-BB63-A64230F5207C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37c3902c0c3882cff87a7e8bb8b21cf64904986d
P2860
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.